Next Article in Journal
Antiepileptic Drug Tiagabine Does Not Directly Target Key Cardiac Ion Channels Kv11.1, Nav1.5 and Cav1.2
Next Article in Special Issue
Regioselective Reduction of 1H-1,2,3-Triazole Diesters
Previous Article in Journal
Spruce Bark-Extracted Lignin and Tannin-Based Bioresin-Adhesives: Effect of Curing Temperatures on the Thermal Properties of the Resins
Previous Article in Special Issue
Xylochemical Synthesis and Biological Evaluation of Shancigusin C and Bletistrin G
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Challenges in the Highly Selective [3 + 1]-Cycloaddition of an Enoldiazoacetamide to Form a Donor–Acceptor Cis-Cyclobutenecarboxamide †

Department of Chemistry, The University of Texas at San Antonio One UTSA Circle, San Antonio, TX 78249, USA
*
Author to whom correspondence should be addressed.
Dedicated to Albert Padwa for his contributions to chemistry.
Molecules 2021, 26(12), 3520; https://doi.org/10.3390/molecules26123520
Submission received: 16 May 2021 / Revised: 28 May 2021 / Accepted: 31 May 2021 / Published: 9 June 2021

Abstract

:
A substituted donor–acceptor cyclobutenecarboxamide is synthesized with modest enantiocontrol through a chiral copper(I) complex catalyzed [3 + 1]-cycloaddition reaction of α-acyl diphenylsulfur ylides with 3-siloxy-2-diazo-3-butenamides. With a methyl substituent on the 4-position of the 3-butenamide, the cis-vicinal-3,4-disubstituted cyclobutenecarboxamide is formed with >20:1 diastereocontrol. Donor-acceptor 3-methyl-2-siloxycyclopropenecarboxamide is rapidly formed from the reactant enoldiazoamide and undergoes catalytic ring opening to give only the Z-γ-substituted metallo-enolcarbene. Elimination from 3-siloxy-2-diazo-3-pentenamide to form the conjugated 3-siloxy-2,4-pentadienamide is competitive but minimized at low temperature.

Graphical Abstract

1. Introduction

The four-membered carbon ring is an important structural framework present in natural products and biologically active compounds, but is less accessible than are other ring structures [1,2,3]. Furthermore, cyclobutanes and cyclobutenes are integral to synthetic strategies involving facile ring-expansion or ring-cleavage reactions [4,5]. The synthesis of cyclobutenes is normally relegated to [2 + 2]-cycloaddition reactions between alkynes and activated alkenes [6,7,8,9,10,11,12,13,14,15], and diastereocontrol for the synthesis of 3,4-disubstituted cyclobutenes is controlled by the geometrical isomerism of the reactant alkyne. Until recently [16,17], however, there were no examples of a broadly applicable enantioselective version of this [2 + 2]-cycloaddition process. Diastereocontrol is conveniently established by the alkene reactant with this methodology; enantiocontrol is the challenge (Figure 1a).
Previous research from our laboratory established that catalytic [3 + 1]-cycloaddition of silyl group-protected enoldiazoacetate esters with α-acyl dimethylsulfur ylides was effective in forming stable donor−acceptor cyclobutene derivatives (Figure 1b) [18]. This methodology produced 1,2,4-trisubstituted (R1 = H) 2-siloxycyclobutenecarboxylates in good yields with uniformly high enantiocontrol. Diastereoselectivity for the formation of 1,2,3,4-tetrasubstituted (R1 = Me) 2-siloxycyclobutenecarboxylates was good (>10:1) to excellent (>20:1) with the trans isomer dominant; however, even in this earlier study there were indications that formation of the cis-diastereomer could be competitive.
Prior research has suggested that diazoamides are more stable and more selective in their catalytic reactions emanating from metal carbene intermediates [19,20], and we anticipated that this selectivity could be applied to catalytic [3 + 1]-cycloaddition of silyl group protected enoldiazoacetamides. However, initial efforts indicated that the same conditions and catalysts that were effective with enoldiazoacetates were not as productive or selective with enoldiazoacetamides. In particular, reactions with α-acyl dimethylsulfur ylides gave low yields for the cycloaddition product, and stereoselectivities were low. To enhance both the efficiency of the transformation and its selectivity to produce substituted donor–acceptor cyclobutenecarboxamides with exceptional stereocontrol, we undertook a comprehensive effort to optimize reactants, conditions, and catalyst ligands to achieve high yields, as well as high enantioselectivities and diastereocontrol (Figure 1c).

2. Results and Discussion

We began our investigation with the cycloaddition of TIPS-protected N,N-dimethyl-enoldiazoacetamide 1a with α-benzoyl dimethylsulfur ylide 2a using the same copper(I) catalyst and chiral ligand (L1, Scheme 1) that were most effective in reactions with enoldiazoacetates (Figure 2) [18]. However, reaction at room temperature under the same conditions produced the [3 + 1]-cycloaddition product 3a in 58% yield having 0% ee after complete dinitrogen extrusion of 1a (Table 1, entry 1). Since phenyl in place of methyl increases the reactivity of the sulfur ylide [21], α-benzoyl diphenylsulfur ylide 2b was prepared [22,23,24,25], and its reaction with 1a under the same conditions gave 3a in 85% yield with 17% ee (Table S1, entry 2, Supplementary Materials). The major enantiomer was assigned to be R based on its correlation in sign of rotation and relative retention volume by HPLC compared with the [3 + 1]-cycloaddition product with the corresponding enoldiazoacetate [18].

2.1. Ligand Control of Enantioselectivity in the [3 + 1]-Cycloaddition of 2-Diazo-N,N-dimethyl-3-(triisopropylsiloxy)but-3-enamide

Using the 4-phenyl-Sabox L1, the ester analog of 1a, methyl enoldiazoacetate, was able to reach 83% ee in its [3 + 1]-cycloaddition reaction with 2b. That 17% ee (Table S1, entry 2) could be achieved in reactions with N,N-dimethyl-enoldiazoacetamide 1a was surprising and not easily explained as due to the size of dimethylamido relative to methoxy groups, nor by the expected electronic influence of amide relative to ester groups on the diazo carbon. Consequently, we directed our attention to expanding our search for ligands that might increase enantioselectivity with a survey of Box (bis-oxazoline) and SaBox (sidearmed bis-oxazoline) ligands (Scheme 1).
To determine the ability of ligands to enhance enantiocontrol in the [3 + 1]-cycloaddition reactions of N,N-dimethyl-enoldiazoacetamide 1a with ylides 2a or 2b using CuOTf·Tol1/2, the series of Box and Sabox ligands (L2L17 in Scheme 1) were screened (Table 1 and Supplementary Materials). Low enantioselectivities (~5% ee) and product yields were achieved in copper(I) catalyzed reactions with the dimethylsulfur ylide 2a using L3, L12, and L17 (55–60% yield, 5% ee, Table S1, entries 5, 12, 18). However, changing to the α-benzoyl diphenylsulfur ylide (2b) brought about an increase in enantioselectivity (34% ee) using Box L2 (Table S1, entry 3), which was greater than that with Sabox L1, but Sabox L5 (Table 1, entry 2) with the 3,5-di-tert-butylbenzyl sidearm gave a near doubling in % ee. Use of indanyl Sabox ligands L6L8 (Table S1, entries 7, 8, 9) were disappointing with ee’s less than 15%, but L9, and L10 provided modest enantiocontrol (Table 1, entries 3, 4). Only with the cis-3,4-diphenyl Sabox ligands did enantiocontrol reach beyond 60% ee, and L17 (Table 1, entry 10) was designated to be the optimum ligand. Lowering the temperature increased the ee by 4% for each 20-degree decrease (Table 1, entries 10, 11, 12). The use of CuBF4(CH3CN)4 in place of CuOTf·Tol1/2 had no meaningful influence on % yield or enantioselectivity (Table 1, entries 13, 14, 15). Use of alternative solvents, including DCE, toluene, and ethyl ether, with L17 led to much lower % ee values (see Supplementary Materials, Scheme S1, Table S2).

2.2. Ligand Control of Diastereoselectivity and Enantioselectivity in the [3 + 1]-Cycloaddition of 2-Diazo-N,N-dimethyl-3-(triisopropylsiloxy)pent-3-enamide

With moderate enantioselectivity in place for the [3 + 1]-cycloaddition of N,N-dimethyl-enoldiazoacetamide 1a with α-benzoyl diphenylsulfur ylide 2b, our next goal was controlling diastereoselectivity. Use of the γ-methyl-substituted 1b was anticipated to result in the formation of vicinal 3,4-disubstituted donor-acceptor cyclobutene 3b which can be produced as either the cis (Z-3b) or trans (E-3b) diastereomer [26,27,28,29]. Prior results from the corresponding γ-methyl-enoldiazoacetate showed a substantial increase in enantioselectivity (to 95% ee) over reactions with the enoldiazoacetate without γ-substitution (83% ee), but a reduction in the dr (diastereomeric ratio) from t:c > 20:1 with 2a to t:c = 13:1 with 2b [18] so we anticipated an increase in enantioselectivity but a further decrease in the t:c ratio in reactions of 1b with 2b. γ-Methyl-substituted 1b prepared by TIPS transfer from TIPSOTf to the precursor α-diazo-β-ketoacetamide promoted by triethylamine yielded 1b (Scheme 2) having a 3:1 E:Z ratio [30]; the expected [3 + 1]-cycloaddition reaction with this stereomeric mixture catalyzed by CuOTf·Tol1/2/L17 produced both Z-3b and E-3b in a 7:1 ratio (Table S3, entry 1, Supplementary Materials) for a reversal in diastereocontrol but in low yield (35%), so we surveyed ligands again and found that L14 gave the highest yield of Z-3b (57%) with a Z/E-3b ratio of 6 (64% ee):1(7% ee) along with the surprising production of diene 4 (22% yield) for an overall yield of 89% (Scheme 3). Recognizing that the individual isomers of 1b could be acting differently in this catalytic reaction, we prepared Z-1b (25:1 Z:E, Scheme 4) [30] and subjected this diazo compound to the same reaction conditions and found both Z-3b and E-3b in a 9:1 ratio (77% yield with 68% ee for Z-3b and 20% ee for E-3b), along with 4 (15% yield). Since the donor-acceptor cyclopropene formed from the reactant enoldiazoacetamide 1b could be the resting state for the intermediate metallo-enolcarbene [31], we prepared cyclopropene 5 (Scheme 5) [32] and subjected this compound to the same reaction conditions to find both Z-3b and E-3b in a 12:1 ratio (73% yield with 71% ee for Z-3b and 16% ee for E-3b), along with 4 (8% yield). The same reaction performed at −20 °C showed much higher selectivity overall (Scheme 3), with an impressive 24:1 Z-3b:E-3b ratio and 79% ee for the cis diastereoisomer, and significantly less diene (Scheme 3).

2.3. Ligand Control of Enantioselectivity in the [3 + 1]-Cycloaddition of 2-Diazo-N,N-dimethyl-3-methyl-2-(triisopropylsiloxy)-1-cyclopropenecarboxamide

The discovery that there was such a substantial reverse in diastereoselectivity in reactions performed with the enoldiazoacetamide (1b) from that found with the corresponding enoldiazoacetate was surprising and prompted investigation of the effect of the ligand L on diastereocontrol. To avoid perturbations in selectivities arising from the different reactivities and selectivities of E- and Z-1b, we chose to use donor-acceptor cyclopropene 5 as the carbene source. Previous results have shown that the donor-acceptor cyclopropene undergoes ring opening with transition metal catalysts to form only the Z-metallo-enolcarbene isomer [31]. We surveyed a representative series of Box and Sabox ligands for [3 + 1]-cycloaddition with 2b, and these results are given in Table 2. As previously stated, yields of [3 + 1]-cycloaddition products are limited by the competing formation of diene 4. However, even with this limitation, L14 (Table 2, entry 6) produced Z-3b with a 12:1 Z:E ratio at room temperature and allowed the isolation of pure Z-3b in 67% yield with 71% ee, and a higher yield, dr and % ee were achieved when the reaction was performed at −20 °C (Table 2, entry 7).

3. Materials and Methods

3.1. General Information

All reactions, unless noted, were performed in oven-dried (120 °C) glassware with magnetic stirring under an inert atmosphere of dry nitrogen. Analytical thin layer chromatography was carried out using EM Science silica gel 60 F254 plates (MilliporeSigma, Burlington, MA, USA); visualization was accomplished with UV light (254 nm). Column chromatography was performed on CombiFlash® Rf200 and Rf+ purification systems (Teledyne Technologies, Thousand Oaks, CA, USA) using normal phase disposable columns. 1H-NMR spectra were recorded on a Bruker spectrometer (500 MHz, Bruker Corporation, Billerica, MA, USA). Chemical shifts were reported in ppm downfield from tetramethylsilane with the solvent resonance as the internal standard (CDCl3, δ = 7.28). Spectra were reported as follows: chemical shift (δ ppm), multiplicity (br = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, comp = composite of magnetically non-equivalent protons, dd = doublet of doublets, td = triplet of doublets; dt = doublet of triplets), coupling constants (Hz), integration and assignment. 13C-NMR spectra were collected on Bruker instrument (125 MHz, Bruker Corporation) with complete proton decoupling. Chemical shifts are reported in ppm from the tetramethylsilane with the solvent resonance as internal standard (CDCl3, δ = 77.0). High-resolution mass spectra (HRMS) were performed on a Bruker MicroTOF-ESI mass spectrometer (Bruker Corporation) with an ESI resource using CsI or LTQ ESI positive ion calibration solution as the standard. Enantioselectivities were determined by HPLC analysis at 25 °C using an Agilent 1260 Infinity HPLC System (Agilent-Technologies, Santa Clara, CA, USA) equipped with an G1311B quaternary pump, G1315D diode array detector, G1329B auto-sampler, G1316A thermostated column compartment and G1170A valve drive. For instrument control and data processing, Agilent OpenLAB CDS ChemStation Edition (1200-series) for LC & LC/MS Systems (Rev. C.01.07 [26]) software was used. Chiralpak OD-H (0.46 mm × 250 mm) columns were obtained from Daicel Chiral Technologies (Chiral Technologies Inc., West Chester, PA, USA). Tetrahydrofuran, dichloromethane, chloroform, and toluene were purified using a JC Meyer solvent purification system. All other solvents were purified and dried using standard methods.

3.2. Abbreviations

EtOAc—ethyl acetate, THF—tetrahydrofuran, MeOH—methanol, DCM—dichloromethane, TEA—triethylamine, MeCN—acetonitrile, i-PrOH—2-propanol, TLC—thin layer chromatography, TMS—tetramethylsilane (Purchased from Fisher Scientific, Waltham, MA, USA).

3.3. Materials

1a, 2b and 5 [18,30,32,33,34], ligands [35,36] and sulfur ylides [22,23,24,25] were prepared by reported methods. All commercially available reagents were used without further purification unless otherwise noted. Preparation of racemic-3a was discussed in Figure 2. Compound 1a was prepared from known diazoketone (6) using TIPSOTf and Et3N in DCM [18]. Compound 8 was made from known compound N,N-dimethyl-3-oxopentanamide 7 using p-ABSA in acetonitrile [35] as shown in Scheme 6.

3.4. General Procedure for Asymmetric Catalytic [3 + 1]-Cycloaddition to Prepare (R)-4-Benzoyl-N,N-dimethyl-2-(triisopropylsiloxy)cyclobut-1-ene-1-Carboxamide (3a)

To an oven-dried sealable 2-dram vial equipped with a stir bar were added CuOTf·Tol1/2 (12.93 mg 0.05 mmol, 5 mol%) and L17 (51.84 mg, 0.06 mmol, 6 mmol%). After the vial was evacuated and backfilled with N2 three times, dry DCM (1.0 mL) was added via a syringe, and the resulting solution was stirred at room temperature for 1 h before the sulfur ylide 2b (310.0 mg, 1.00 mmol, 1.0 equiv.) dissolved in dry DCM (0.5 mL) was added dropwise via a syringe. The reaction was stirred at room temperature for 5 min, and a solution of 2-diazo-N,N-dimethyl-3-(triisopropylsiloxy)but-3-enamide (1a, 373.2 mg, 1.20 mmol, 1.2 equiv.) in dry DCM (1.0 mL) was then added dropwise at rt for 1 h. The reaction mixture was stirred at the same temperature for 16 h, filtered through a short pad of silica gel and washed. Then the reaction solution was filtered through a short pad of Celite. The filtrate was concentrated, and the residue was purified by flash chromatography on silica gel using 10:3 hexanes:ethyl acetate as the eluent to afford (R)-4-benzoyl-N,N-dimethyl-2-(triisopropylsiloxy)cyclobut-1-ene-1-carboxamide (3a) as a colorless liquid. 79% yield, 315 mg, 60% ee, HPLC conditions for determination of enantiomeric excess: Chiralpak OD-H column, 254 nm, hexanes/i-PrOH = 97:3, 1.1 mL/min, tr (1) = 13.00 min, tr (2) = 14.35 min; 1H-NMR (500 MHz, CDCl3) δ 8.12–8.09 (m, 2H), 7.55 (tt, J = 7.3, 2.2 Hz, 1H), 7.50–7.45 (m, 2H), 4.51 (dd, J = 5.0, 1.9 Hz, 1H), 3.23 (s, 3H), 3.94 (s, 3H), 2.88 (dd, J = 13.3, 5.0 Hz, 1H), 2.77 (dd, J = 13.3, 1.9 Hz, 1H), 1.26–1.18 (m, 3H), 1.15–1.08 (comp, 18H); 13C-NMR (125 MHz, CDCl3) δ 200.6, 163.5, 147.9, 136.7, 132.9, 128.5, 128.4, 111.7, 38.8, 37.7, 36.1, 34.8, 17.6, 12.5 ppm; HRMS (ESI) m/z calcd for C23H35NO3Si: [M + H]+ 416.2459; found: 416.2448.

3.5. Preparation of 4-Benzoyl-N,N-Dimethyl-2-(triisopropylsiloxy)cyclobut-1-ene-1-carboxamide (Racemic 3a)

To an oven-dried sealable 2-dram vial equipped with a stir bar were added CuOTf·Tol1/2 (4.6 mg, 0.018 mmol, 5 mol%) and sulfur ylide 2b (91.1 mg, 0.36 mmol, 1.0 equiv.). After the vial was evacuated and backfilled with N2 three times, dry DCM (2.0 mL) was added via a syringe; and the solution was stirred at room temperature for 5 min before 2-diazo-N,N-dimethyl-3-(triisopropylsiloxy)but-3-enamide (1a, 127.1 mg, 0.36 mmol, 1.2 equiv.) dissolved in dry DCM (2.0 mL) was added dropwise via a syringe for 1 h. The reaction solution was stirred at room temperature for 16 h then filtered through a short pad of Celite and washed with DCM. The filtrate was concentrated, and the residue was purified by flash chromatography on silica gel using 10:3 hexanes:ethyl acetate as the eluent to afford the corresponding racemic [3 + 1]-cycloaddition product 4-benzoyl-N,N-dimethyl-2-(triisopropylsiloxy)cyclobut-1-ene-1-carboxamide (Racemic 3a) as a colorless liquid (115 mg, 87%). Enantiomer composition was determined by HPLC analysis [Daicel chiralpak OD-H, hexanes/i-PrOH = 97/3, 1.0 mL/min, λ = 254 nm, t1 = 13.90 min, t2 = 15.69 min.

3.6. Preparation of 2-Diazo-N,N-dimethyl-3-(triisopropylsiloxy)but-3-enamide (1a)

To a 100 mL oven-dried round bottom flask containing a magnetic stirring bar, commercially available 2-diazo-N,N-dimethyl-3-oxobutanamide (6, 1.0 equiv., 5.18 g, 33.41 mmol) and Et3N (1.5 equiv., 6.97 mL, 50.12 mmol) in DCM (100 mL) were added TIPSOTf (1.1 equiv., 9.87 mL, 36.75 mmol) slowly at 0 ℃. After the reaction mixture was stirred for 30 min, hexane (150 mL) was added, followed by saturated aqueous NaHCO3 solution (40 mL). The organic phase was separated and washed two more times with saturated aqueous NaHCO3 solution (40 mL × 2) then dried with anhydrous Na2SO4. After evaporating the solvents, the residue was then purified by flash chromatography (SiO2 was treated with hexanes with 5% Et3N for 10 min before use, hexanes 100% then 10:1 hexanes; ethyl acetate as the eluent) to afford 10.01 g (95%) of 2-diazo-N,N-dimethyl-3-(triisopropylsiloxy)but-3-enamide (1a) as yellow color liquid; 1H-NMR (500 MHz, CDCl3) δ 4.45 (d, J = 2.2 Hz, 1H), 4.27 (d, J = 2.2 Hz, 1H,), 3.00 (s, 6H), 1.31–1.21 (m, 3H), 1.14–1.08 (comp, 18H); 13C-NMR (125 MHz, CDCl3) δ 165.0, 143.8, 89.6, 37.4, 17.7, 17.4, 12.6, 12.3 ppm; HRMS (ESI) m/z calculated for C15H27N3O2Si: [M + H]+ 312.2102; found 312.2096.

3.7. General Procedure for Catalytic [3 + 1]-Cycloaddition Reaction of Sulfur Ylides (2b) with 1b or Cyclopropenecarboxamides (5)

3.7.1. General Procedure for Asymmetric Catalytic CuOTf-Catalyzed [3 + 1]-Cycloaddition Reactions to Prepare Z-3b and E-3b from 1b (Z:E = 1:3) or 1b (Z:E = 25:1)

To an oven-dried sealable 2-dram vial equipped with a stir bar were added CuOTf·Tol1/2 (2.6 mg, 0.010 mmol, 5 mol%) and bisoxazoline ligand L14 (6.1 mg, 0.012 mmol, 6 mol%). After the vial was evacuated and backfilled with N2 three times, dry DCM (1.0 mL) was added via a syringe and the resulting solution was stirred at room temperature for 1 h before sulfur ylide 2b (60.8 mg, 0.20 mmol, 1.0 equiv.) dissolved in dry DCM (0.5 mL) was added dropwise via a syringe. The reaction was stirred at room temperature for 5 min and then a solution of cyclopropenecarboxamide 1b (78.0 mg, 0.24 mmol, 1.2 equiv.) in dry DCM (1.0 mL) was then added dropwise for 1 h. The reaction mixture was stirred at the same temperature for 24 h, filtered through a short pad of silica gel and washed with DCM. The filtrate was further concentrated and directly subjected to analysis by 1H-NMR. After that, the residue was purified by flash chromatography on silica gel using 10:0 to 10:3 hexanes:ethyl acetate as the eluent to afford the expected [3 + 1]-cycloaddition product Z-3b, E-3b and diene (4).
For 1b (Z:E-1b = 1:3) using Ligand L14, Ylide 2b at rt, 24 h: Scale 0.2 mmol, dr 6:1 (Z-3b:E-3b), 47 mg of Z-3b as colorless liquid, 57% yield, 64% ee; 10% of E-3b, 7% ee and 15 mg (22%) of 4 as colorless liquid; HPLC conditions for determination of enantiomeric excess of Z-3b: Chiralpak OD-H column, 254 nm, hexanes/i-PrOH = 97:3, 1.0 mL/min, tr (minor) = 13.15 min, tr (major) = 17.19 min; HPLC conditions for determination of enantiomeric excess of E-3b: Chiralpak OD-H column, 254 nm, hexanes/i-PrOH = 97:3, 1.0 mL/min, tr (minor) = 11.31 min, tr (major) = 9.63 min.
For 1b (Z:E-1b = 25:1) using Ligand L14, Ylide 2b at rt, 24 h: Scale 0.2 mmol, dr 9:1 (Z-3b:E-3b), 56 mg of Z-3b as colorless liquid, 69% yield, 68% ee; 8% of E-3b, 20% ee and 10 mg (15%) of 4 as colorless liquid; HPLC conditions for determination of enantiomeric excess of Z-3b: Chiralpak OD-H column, 254 nm, hexanes/i-PrOH = 97:3, 1.0 mL/min, tr (minor) = 13.61 min, tr (major) = 18.10 min; HPLC conditions for determination of enantiomeric excess of E-3b: Chiralpak OD-H column, 254 nm, hexanes/i-PrOH = 97:3, 1.0 mL/min, tr (minor) = 11.34 min, tr (major) = 9.61 min.

3.7.2. General Procedure for Asymmetric Catalytic [3 + 1]-Cycloaddition to Prepare Z-3b and E-3b from 5

To an oven-dried sealable 2-dram vial equipped with a stir bar were added CuOTf·Tol1/2 (2.6 mg, 0.010 mmol, 5 mol%) and bisoxazoline ligand L14 (6.1 mg, 0.012 mmol, 6 mol%). After the vial was evacuated and backfilled with N2 three times, dry DCM (1.0 mL) was added via a syringe and the resulting solution was stirred at room temperature for 1 h before sulfur ylide 2b (61 mg, 0.20 mmol, 1.0 equiv.) dissolved in dry DCM (0.5 mL) was added dropwise via a syringe for 1 h. The reaction was stirred at room temperature for 5 min and then a solution of cyclopropenecarboxamide 5 (71 mg, 0.24 mmol, 1.2 equiv.) in dry DCM (0.5 mL) was then added dropwise. The reaction mixture was stirred at the same temperature for 24 h, filtered through a short pad of silica gel and washed with hexanes/EtOAc (1:1, 10 mL). The filtrate was further concentrated and directly subjected to analysis by 1H-NMR. After that, the residue was purified by flash chromatography on silica gel using 10:0 to 10:3 hexanes:ethyl acetate as the eluent to afford to afford the expected [3 + 1]-cycloaddition product Z-3b, E-3b and diene (4).
For 5 using Ligand L14, Ylide 2b at rt, 24 h: Scale 0.2 mmol, dr 12:1 (Z-3b:E-3b), 56 mg of Z-3b as colorless liquid, 67% yield, 71% ee; 5.5% of E-3b, 16% ee and 5.5 mg (8%) of 4 as colorless liquid; HPLC conditions for determination of enantiomeric excess of Z-3b: Chiralpak OD-H column, 254 nm, hexanes/i-PrOH = 97:3, 1.0 mL/min, tr (minor) = 13.65 min, tr (major) = 17.76 min; HPLC conditions for determination of enantiomeric excess of E-3b: Chiralpak OD-H column, 254 nm, hexanes/i-PrOH = 97:3, 1.1 mL/min, tr (minor) = 11.50 min, tr (major) = 9.74 min.
(3R,4S)-4-Benzoyl-3-methyl-N,N-dimethyl-2-(triisopropylsiloxy)cyclobut-1-ene-1-carboxamide (Z-3b): 1H-NMR (500 MHz, CDCl3) δ 7.94 (d, J = 7.5 Hz, 2H), 7.54 (t, J = 7.5 Hz, 1H), 7.44 (t, J = 7.5 Hz, 2H), 4.64 (d, J = 4.9 Hz, 1H), 3.39–3.33 (m, 1H), 3.29 (s, 3H), 2.97 (s, 3H), 1.23–1.05 (comp, 21H), 0.97 (d, J = 6.9 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 199.4, 164.3, 150.3, 137.2, 132.9, 128.5, 128.2, 110.6, 44.5, 43.0, 37.9, 34.7, 17.5, 13.0, 12.6; HRMS (ESI) m/z calcd for C24H37NO3Si: [M + H]+ 416.2615; found: 416.2610.
(3R,4R)-4-Benzoyl-3-methyl-N,N-dimethyl-2-(triisopropylsiloxy)cyclobut-1-ene-1-carboxamide (E-3b): 1H-NMR (500 MHz, CDCl3) δ 8.06 (d, J = 7.4 Hz, 2H), 7.58–7.54 (m, 1H), 7.48 (t, J = 7.4 Hz, 2H), 4.01 (d, J = 1.4 Hz, 1H), 3.21 (brs, 3H), 3.01–2.95 (m, 1H), 2.93 (brs, 3H), 1.42 (d, J = 7.1 Hz, 3H), 1.23–1.05 (comp, 21H).
N,N-Dimethyl-3-triisopropylsiloxy-2,4-pentadienecarboxamide (4): 1H-NMR (500 MHz, CDCl3): δ 6.20 (dd, J = 17.1, 10.7 Hz, 1H), 5.64 (dd, J = 17.1, 1.2 Hz, 1H), 5.32 (s, 1H), 5.24 (dd, J = 10.7, 1.2 Hz, 1H), 3.06 (s, 3H), 2.97 (s, 3H), 1.24–1.18 (comp, 3H), 1.16–1.08 (comp, 18H); 13C-NMR (125 MHz, CDCl3) δ 167.3, 153.3, 135.3, 117.0, 37.9, 34.6, 17.9, 13.5; HRMS (ESI) m/z calcd for C16H31NO2Si: [M + H]+ 298.2197; found: 298.2193.

3.8. Preparation of 2-Diazo-N,N-dimethyl-3-oxopentanamide (8)

To a stirred solution of N,N-dimethyl-3-oxopentanamide [35] (7, 3.00 g, 21.0 mmol) and p-acetamidobenzenesulfonyl azide (p-ABSA, 5.00 g, 21.0 mmol) in acetonitrile (80 mL), Et3N (8.75 mL, 63.0 mmol) was added dropwise at 0 °C over 3 min. The reaction mixture was warmed to room temperature and stirred for 16 h. Acetonitrile was then removed under reduced pressure, and the residue was redissolved in dichloromethane. The sulfonamide precipitate was filtered, and the filtrate was concentrated under reduced pressure. The residue was then purified by silica gel column chromatography using a 10:4 to 10:6 gradient of hexane/ethyl acetate (v/v) as the eluent to afford 2.95 g (83%) of 2-diazo-N,N-dimethyl-3-oxopentanamide (8) as yellow color liquid. 1H-NMR (500 MHz, CDCl3) δ 3.00 (s, 6H), 2.65 (q, J = 7.3 Hz, 2H), 1.14 (t, J = 7.3 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 192.7, 161.3, 37.4, 32.4, 8.3 ppm; HRMS (ESI) m/z calculated for C7H11N3O2: [M + H]+ 170.0924; found 170.0923.

3.9. Preparation of 2-Diazo-N,N-dimethyl-3-((triisopropylsiloxy)pent-3-enamide, 1b (Z:E-1b = 1:3)

1b (Z:E = 1:3) was prepared from 2-diazo-N,N-dimethyl-3-oxopentanamide (8) according to reported [18,32] procedure using TIPSOTf (1.1 equiv.), Et3N (1.5 equiv.) and LiCl (1.0 equiv.). Its Z/E ratio was determined by 1H-NMR spectroscopy and 10% formation of cyclopropene 5 was observed compared to total olefin (E + Z). For simplicity only 1H-NMR of E isomer was given here; yield 95%; 1H-NMR of E (500 MHz, CDCl3) δ 4.93 (q, J = 7.1 Hz, 1H), 2.99 (s, 6H), 1.57 (d, J = 7.1 Hz, 3H), 1.32–1.02 (m, 21H); HRMS (ESI) m/z calculated for C16H31N3O2Si: [M + H]+ 326.2258; found 326.2253.

3.10. Preparation of 2-Diazo-N,N-dimethyl-3-(triisopropylsiloxy)pent-3-enamide, 1b (Z:E-1b = 25:1)

The reported [30] procedure was modified to make 2-diazo-N,N-dimethyl-3-((triisopropylsiloxy)pent-3-enamide (Z:E-1b = 25:1). The title compound includes a small percent (5–10%) of cyclopropenecarboxamide 5 because enoldiazoacetamide undergoes dinitrogen extrusion to form cyclopropenecarboxamide, even when stored at 0 °C. Compound 1b (Z:E = 25:1) in common NMR solvents (CDCl3, CD2Cl2, DMSOd6, CD3NO2 and hexanes) is converted (at 0 °C) to the corresponding cyclopropene (5), but was found to be stable at −20 °C and should be stored at −20 °C. At 0 °C and rt, 20% and 70%, formation of 5 was observed after 6 h respectively.
To a 100-mL oven-dried vial equipped with a magnetic stirring bar, 2-diazo-N,N-dimethyl-3-oxopentanamide (8, 200 mg, 1.18 mmol) was added, and the system was filled with nitrogen. THF (30 mL) was then added, and the reaction solution was cooled to −78 °C (dry ice/acetone bath), LiHMDS (1.30 mL, 1.0 M in the hexanes) was introduced dropwise over 2 min, followed by the addition of TIPSOTf (0.315 mL, 1.18 mmol) at −78 °C. The resulting solution was stirred at −78 °C until the reaction was complete (monitored by TLC, about 5−15 min). The reaction was quenched at −78 °C with ice-cold brine, and solvent was removed at 15 °C under reduced pressure, and the residue was directly purified by column chromatography on silica gel which was pre-treated with 5 vol.% triethylamine/hexanes (eluent: pure hexanes then 10% EtOAc in hexanes) to give the desired product 2-diazo-N,N-dimethyl-3-(triisopropylsiloxy)pent-3-enamide, 1b (Z:E-1b = 25:1) as yellow liquid which was immediately stored −20 °C. 1H-NMR of 1b-Z (500 MHz, CDCl3) δ 5.00 (q, J = 6.9 Hz, 1H, Z-H), 3.01 (s, 6H, NCH3), 1.70 (d, J = 6.9 Hz, 3H, CH3), 1.32–1.02 (m, 21H, TIPS); 13C-NMR of 1b-Z including 5 (125 MHz, CDCl3) δ 160.7, 142.5, 79.6, 37.1, 34.6, 34.5, 31.5, 25.8, 25.2, 22.6, 20.3, 17.7, 17.4, 17.4, 14.1, 12.3, 12.0, 11.8 ppm; HRMS (ESI) m/z calculated for C16H31N3O2Si: [M + H]+ 326.2258; found 326.2254.

3.11. Preparation of N,N,3-Trimethyl-2-(triisopropylsiloxy)cycloprop-1-ene-1-carboxamide (5)

2-Diazo-N,N-dimethyl-3-(triisopropylsiloxy)pent-3-enamide, 1b (Z:E-1b = 1:3) (1.00 g, 3.17 mmol) at room temperature was added to a 20 mL oven dried vial containing a magnetic stirring bar and 10 mL CHCl3, and then the vial was screwed close. The sealed reaction mixture was heated in oil bath at 50 °C for 2 h, during this time the diazo compound was converted to the corresponding cyclopropene. The color of the solution changed from yellow to colorless. Solvent was removed under reduced pressure to afford 980 mg (>99%) of N,N,3-trimethyl-2-(triisopropylsiloxy)cycloprop-1-ene-1-carboxamide (5) was obtained as colorless liquid and was characterized directly without further purification. Compound 5 was also obtained heating 1b (Z:E-1b = 25:1) in CHCl3 at 50 °C for 1 h. 1H-NMR (500 MHz, CDCl3) δ 3.16 (s, 3H), 2.99 (s, 3H), 2.38 (q, J = 4.9 Hz, 1H), 1.30 (d, J = 4.9 Hz, 3H), 1.36–1.24 (comp, 3H), 115–1.10 (comp, 18H); 13C-NMR (125 MHz, CDCl3) δ 160.7, 142.5, 79.6, 37.1, 34.5, 25.8, 20.3, 17.9, 17.8, 17.7, 17.7, 17.5, 17.4, 17.4, 12.3, 12.0 ppm; HRMS (ESI) m/z calculated for C16H31NO2Si: [M + H]+ 298.2197; found 298.2193.

4. Conclusions

The influence of ligands on stereocontrol with γ-methyl-substituted 1b is surprisingly diverse. Diastereoselectivity favoring the cis isomer ranges from 2:1 with SaBox ligand L1 (Table 2, entry 1) to >20:1 with the tetramethylene SaBox ligand L14 (Table 2, entry 7) (the cis-4,5-diphenyl-Box template) providing the highest diastereocontrol. The highest enantioselectivity is also found with L14 (Table 2, entries 6, 7) which appears to be the optimum between smaller (L12, Table 2, entry 5) and larger (L16 and L17, Table 2, entries 8, 9) attachments. Similarly, the cis-4,5-diphenyl-Box template of L14 (Table 2, entry 6) provides higher stereocontrol than the analogous indanyl-Box template of L11 (Table 2, entry 4). For [3 + 1]-cycloaddition with N,N-dimethyl-enoldiazoacetamide 1a ligand L14 (Table 1, entry 7) exhibited much lower enantioselectivity, 34% ee compared to 60% ee with L17 (Table 1, entry 10), demonstrating a significant dependence of enantioselectivity on the chiral ligand. However, enantioselctivity for formation of the trans donor-acceptor cyclobutene isomer E-3b was very low in comparison and exhibited no obvious means for improvement with the ligands that were employed. Attempted extension of this methodology to the γ-ethyl-substituted enoldiazoacetamide using the same copper catalyst with ligand L14 at room temperature gave low product yield, low diastereoselectivity (2:1 cis:trans) and low enantioselectivity, which further signaled the inherent complexity of stereocontrol in these reactions.
The competitive formation of diene 4 was another surprise in this transformation. Not previously observed from reactions with the corresponding enoldiazoacetates [18], this product was observed in variable amounts from all reactions catalyzed by copper(I) with Box or Sabox ligands. However, diene 4 (Scheme S2, Supplementary Materials) was not formed when the copper catalyzed reaction with ylide 2b was performed without ligand with either enoldiazoacetamide Z-1b or with donor-acceptor cyclopropenecarboxamide 5, and neither the sulfur ylide nor the ligand alone caused diene formation in reactions performed over 24 h. Since a 20% excess of ligand was used to ensure that unligated copper(I) was minimized, we thought that the diene might arise from the ligand, acting as a base, to effect elimination from the intermediate metallo-enol carbene. Indeed, using 2.4 mol% triethylamine in place of the ligand resulted in diene formation (29% yield, Scheme S3, Supplementary Materials). However, limiting the amount of excess ligand in the [3 + 1]-cycloaddition reaction to exactly 1:1 correspondence with the copper catalyst did not reduce the amount of diene 4 formation; but lowering the temperature to −20 °C brought diene formation down to 2%.
In summary, Cu(I) catalyzed asymmetric [3 + 1] cycloaddition of α-benzoyl diphenylsulfur ylide 2b with 3-methyl- or un-substituted cyclopropenecarboxamides gives access to the synthesis of donor-acceptor cyclobutenecarboxamides in good yield and moderate enantioselectivity. Unlike their corresponding enoldiazoacetate, the γ-methyl substituted amide gives a high preference for the cis diastereoisomer. Reactivity and stereoselectivity of the amide and ester are significantly different, and formation of diene 4 from amide 1b suggests an elimination pathway for the intermediate metallo-enolcarbene.

Supplementary Materials

The following are available online: Table S1. Complete Data for Optimization in Catalytic Asymmetric [3 + 1]-Cycloaddition Reactions of 1a with 2a/2b. Table S2. Solvent screening of [3 + 1]-Cycloaddition Reaction of 1a with 2b using ligand 17. Table S3. Complete Data for Optimization in Catalytic Asymmetric [3 + 1]-Cycloaddition Reaction of donor acceptor cyclopropene 5 with 2b. Optimization of Conditions of Diene (4) formation. Scheme S1. Solvent screening of [3 + 1]-Cycloaddition Reaction of 1a with 2b using ligand 17. Scheme S2. Reactants Not Involved in Diene (4) formation. Scheme S3. Optimization of Conditions of Diene (4) formation. 1H- and 13C-NMR spectra of 1a, 3a, Z-3b, 4, 5, 8, (Z:E-1b = 1:3) and (Z:E-1b = 25:1). Selected chiral HPLC spectra of 3a, Z3-b and Z-3b.

Author Contributions

Conceptualization, M.P.D.; methodology, S.J. and D.M.; validation, S.J.; formal analysis, S.J. investigation, S.J. and D.M.; writing—original draft preparation, M.P.D. and S.J. writing—review and editing, M.P.D. and S.J.; supervision, M.P.D.; project administration, M.P.D.; funding acquisition, M.P.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Science Foundation, grant number CHE−1763168.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We acknowledge the U.S. National Science Foundation (CHE−1763168) for funding this research.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.

Sample Availability

Samples of the donor-acceptor cyclopropenes or cyclobutenes described in this manuscript are available from the authors.

References

  1. Antonsen, S.; Østby, R.B.; Stenstrøm, Y. Chapter 1—Naturally Occurring Cyclobutanes: Their Biological Significance and Synthesis. Stud. Nat. Prod. Chem. 2018, 57, 1–40. [Google Scholar]
  2. Dembitsky, V.M. Naturally occurring bioactive Cyclobutane-containing (CBC) alkaloids in fungi, fungal endophytes, and plants. Phytomedicine 2014, 21, 1559–1581. [Google Scholar] [CrossRef]
  3. Dembitsky, V.M. Bioactive cyclobutane-containing alkaloids. J. Nat. Med. 2008, 62, 1–33. [Google Scholar] [CrossRef]
  4. Namyslo, J.C.; Kaufmann, D.E. The Application of Cyclobutane Derivatives in Organic Synthesis. Chem. Rev. 2003, 103, 1485–1538. [Google Scholar] [CrossRef]
  5. Lee-Ruff, E.; Mladenova, G. Enantiomerically Pure Cyclobutane Derivatives and Their Use in Organic Synthesis. Chem. Rev. 2003, 103, 1449–1484. [Google Scholar] [CrossRef]
  6. Ha, S.; Lee, Y.; Kwak, Y.; Mishra, A.; Yu, E.; Ryou, B.; Park, C.-M. Alkyne–Alkene [2 + 2] cycloaddition based on visible light photocatalysis. Nat. Commun. 2020, 11, 1–12. [Google Scholar] [CrossRef]
  7. Bai, Y.-B.; Luo, Z.; Wang, Y.; Gao, J.-M.; Zhang, L. Au-Catalyzed Intermolecular [2 + 2] Cycloadditions between Chloroalkynes and Unactivated Alkenes. J. Am. Chem. Soc. 2018, 140, 5860–5865. [Google Scholar] [CrossRef]
  8. Ogoshi, S.; Kumar, R.; Tamai, E.; Ohnishi, A.; Nishimura, A.; Hoshimoto, Y.; Ohashi, M. Nickel-Catalyzed Enantioselective Synthesis of Cyclobutenes via [2 + 2] Cycloaddition of α,β-Unsaturated Carbonyls with 1,3-Enynes. Synthesis 2016, 48, 2789–2794. [Google Scholar] [CrossRef] [Green Version]
  9. Shen, L.; Zhao, K.; Doitomi, K.; Ganguly, R.; Li, Y.-X.; Shen, Z.-L.; Hirao, H.; Loh, T.-P. Lewis acid-catalyzed selective [2 + 2]-cycloaddition anddearomatizing cascade reaction of aryl alkynes with acrylates. J. Am. Chem. Soc. 2017, 139, 13570–13578. [Google Scholar] [CrossRef]
  10. Yoon, T.P. Visible Light Photocatalysis: The Development of Photocatalytic Radical Ion Cycloadditions. ACS Catal. 2013, 3, 895–902. [Google Scholar] [CrossRef]
  11. Sakai, K.; Kochi, T.; Kakiuchi, F. Rhodium-catalyzed intermolecular [2 + 2] cycloaddition of terminal alkynes with electron-deficient alkenes. Org. Lett. 2013, 15, 1024–1027. [Google Scholar] [CrossRef]
  12. Nishimura, A.; Ohashi, M.; Ogoshi, S. Nickel-catalyzed intermolecular [2 + 2] cycloaddition of conjugated enynes with alkenes. J. Am. Chem. Soc. 2012, 134, 15692–15695. [Google Scholar] [CrossRef]
  13. Fan, B.-M.; Li, X.-J.; Peng, F.-Z.; Zhang, H.-B.; Chan, A.S.C.; Shao, Z.-H. Ligand-controlled enantioselective [2 + 2] cycloaddition of oxabicyclic alkenes with terminal alkynes using chiraliridium catalyst. Org. Lett. 2010, 12, 304–306. [Google Scholar] [CrossRef]
  14. Lopez-Carrillo, V.; Echavarren, A.M. ChemInform Abstract: Gold(I)-Catalyzed Intermolecular [2 + 2] Cycloaddition of Alkynes with Alkenes. J. Am. Chem. Soc. 2010, 41, 9292–9294. [Google Scholar] [CrossRef] [PubMed]
  15. Treutwein, J.; Hilt, G. Cobalt-catalyzed [2 + 2] cycloaddition. Angew. Chem. Int. Ed. 2008, 47, 6811–6813. [Google Scholar] [CrossRef] [PubMed]
  16. Xu, Y.; Conner, M.L.; Brown, M.K. Cyclobutane and Cyclobutene Synthesis: Catalytic Enantioselective [2 + 2] Cycloadditions. Angew. Chem. Int. Ed. 2015, 54, 11918–11928. [Google Scholar] [CrossRef] [PubMed]
  17. Parsutkar, M.M.; Pagar, V.V.; Rajanbabu, T.V. Catalytic Enantioselective Synthesis of Cyclobutenes from Alkynes and Alkenyl Derivatives. J. Am. Chem. Soc. 2019, 141, 15367–15377. [Google Scholar] [CrossRef] [PubMed]
  18. Deng, Y.; Massey, L.A.; Zavalij, P.; Doyle, M.P. Catalytic Asymmetric [3+1]-Cycloaddition Reaction of Ylides with Electrophilic Metallo-enolcarbene Intermediates. Angew. Chem. Int. Ed. 2017, 56, 7479–7483. [Google Scholar] [CrossRef] [PubMed]
  19. Cheng, Q.Q.; Yedoyan, J.; Arman, H.; Doyle, M.P. Dirhodium(II)-Catalyzed Annulation of Enoldiazoacetamides with α-Diazoketones: An Efficient and Highly Selective Approach to Fused and Bridged Ring System. Angew. Chem. Int. Ed. 2016, 55, 5573–5576. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Padwa, A.; Austin, D.J.; Hornbuckle, S.F.; Semones, M.A.; Doyle, M.P.; Protopopova, M.N. Control of Chemoselectivity in Catalytic Carbenoid Reactions. J. Am. Chem. Soc. 1992, 114, 1874–1876. [Google Scholar] [CrossRef]
  21. Kaiser, D.; Klose, I.; Oost, R.; Neuhaus, J.; Maulide, N. Bond-Forming and -Breaking Reactions at Sulfur(IV): Sulfoxides, Sulfonium Salts, Sulfur Ylides, and Sulfinate Salts. Chem. Rev. 2019, 119, 8701–8780. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Ratts, K.W.; Yao, A.N. Stable Sulfonium Ylids. J. Org. Chem. 1966, 31, 1185–1188. [Google Scholar] [CrossRef]
  23. Seshadri, R.; Pegg, W.J.; Israel, M. Diethyl oxomalonate. An improved synthesis. J. Org. Chem. 1981, 46, 2596–2598. [Google Scholar] [CrossRef]
  24. Nozaki, H.; Takaku, M.; Kondô, K. Stable sulphonium phenacylides: Isolation and reactions. Tetrahedron 1966, 22, 2145–2152. [Google Scholar] [CrossRef]
  25. Kramer, S.; Skrydstrup, T. Gold-Catalyzed Carbene Transfer to Alkynes: Access to 2,4-Disubstituted Furans. Angew. Chem. Int. Ed. 2012, 51, 4681–4684. [Google Scholar] [CrossRef] [PubMed]
  26. Shved, A.S.; Tabolin, A.A.; Novikov, R.A.; Nelyubina, Y.V.; Timofeev, V.P.; Ioffe, S.L. Six-Membered Cyclic Nitroso Acetals: Synthesis and Studies of the Nitrogen Inversion Process of N-Silyloxy-3,6-dihydro-2H-1,2-oxazines. Eur. J. Org. Chem. 2016, 2016, 5569–5578. [Google Scholar] [CrossRef]
  27. Zhu, C.; Xu, G.; Sun, J. Gold-Catalyzed Formal [4+1]/[4+3] Cycloadditions of Diazo Esters with Triazines. Angew. Chem. Int. Ed. 2016, 55, 11867–11871. [Google Scholar] [CrossRef]
  28. Nocquet, P.; Opatz, T. Total Synthesis of (±)-Scopolamine: Challenges of the Tropane Ring. Eur. J. Org. Chem. 2016, 2016, 1156–1164. [Google Scholar] [CrossRef]
  29. Xu, X.; Wang, X.; Zavalij, P.Y.; Doyle, M.P. Straightforward Access to the [3.2.2] Nonatriene Structural Framework via Intramolecular Cyclopropenation/Buchner Reaction/Cope Rearrangement Cascade. Org. Lett. 2015, 17, 790–793. [Google Scholar] [CrossRef]
  30. Dong, K.; Marichev, K.O.; Xu, X.; Doyle, M.P. High Stereocontrol in the Preparation of Silyl-Protected γ-Substituted Enoldiazoacetates. Synlett 2019, 30, 1457–1461. [Google Scholar] [CrossRef]
  31. Dong, K.; Marichev, K.O.; Doyle, M.P. The Role of Donor-Acceptor Cyclopropenes in Metal Carbene Reactions. Conversion of E-Substituted Enoldiazoacetates to Z-Substituted Metallo-Enolcarbenes. Organometal 2019, 38, 4043–4050. [Google Scholar] [CrossRef]
  32. Deng, Y.; Jing, C.; Doyle, M.P. Dinitrogen extrusion from enoldiazo compounds under thermal conditions: synthesis of donor–acceptor cyclopropenes. Chem. Commun. 2015, 51, 12924–12927. [Google Scholar] [CrossRef]
  33. Liu, Q.; Rovis, T. Enantio- and Diastereoselective Intermolecular Stetter Reaction of Glyoxamide and Alkylidene Ketoamides. Org. Lett. 2009, 11, 2856–2859. [Google Scholar] [CrossRef] [Green Version]
  34. Ge, L.-S.; Wang, Z.-L.; An, X.-L.; Luo, X.; Deng, W.-P. Direct synthesis of polysubstituted 2-aminothiophenes by Cu(ii)-catalyzed addition/oxidative cyclization of alkynoates with thioamides. Org. Biomol. Chem. 2014, 12, 8473–8479. [Google Scholar] [CrossRef] [PubMed]
  35. Nolin, A.; Ahn, R.W.; Kobayashi, Y.; Kennedy-Smith, J.J.; Toste, F.D. Enantioselective Reduction of Ketones and Imines Catalyzed by (CN-Box)ReV–Oxo Complexes. Chem. Eur. J. 2010, 16, 9555–9562. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Qiao, J.-B.; Zhao, Y.-M.; Gu, P. Asymmetric Intramolecular Desymmetrization of meso-α,α′-Diazido Alcohols with Aryldiazo-acetates: Assembly of Chiral C3 Fragments with Three Continuous Stereocenters. Org. Lett. 2016, 18, 1984–1987. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Cycloaddition reactions that form cyclobutene derivatives: (a) [2 + 2]-cycloaddition; (b) [3 + 1]-cycloaddition of silyl group-protected enoldiazoacetate esters; (c) [3 + 1]-cycloaddition of silyl group-protected enoldiazoacetamides (this work).
Figure 1. Cycloaddition reactions that form cyclobutene derivatives: (a) [2 + 2]-cycloaddition; (b) [3 + 1]-cycloaddition of silyl group-protected enoldiazoacetate esters; (c) [3 + 1]-cycloaddition of silyl group-protected enoldiazoacetamides (this work).
Molecules 26 03520 g001
Scheme 1. Ligands employed in the search for enantioselectivity in the [3 + 1]-cycloaddition reactions of enoldiazoacetamide 1a.
Scheme 1. Ligands employed in the search for enantioselectivity in the [3 + 1]-cycloaddition reactions of enoldiazoacetamide 1a.
Molecules 26 03520 sch001
Figure 2. [3 + 1]-cycloaddition reactions with enoldiazoamide 1a.
Figure 2. [3 + 1]-cycloaddition reactions with enoldiazoamide 1a.
Molecules 26 03520 g002
Scheme 2. Preparation of 2-Diazo-N,N-dimethyl-3-((triisopropylsiloxy)pent-3-enamide, 1b (Z:E-1b = 1:3).
Scheme 2. Preparation of 2-Diazo-N,N-dimethyl-3-((triisopropylsiloxy)pent-3-enamide, 1b (Z:E-1b = 1:3).
Molecules 26 03520 sch002
Scheme 3. Diastereoselectivity and enantioselectivity in [3 + 1]-cycloaddition reactions with γ-methyl enoldiazoamide 1b.
Scheme 3. Diastereoselectivity and enantioselectivity in [3 + 1]-cycloaddition reactions with γ-methyl enoldiazoamide 1b.
Molecules 26 03520 sch003
Scheme 4. Preparation of 2-Diazo-N,N-dimethyl-3-(triisopropylsiloxy)pent-3-enamide, 1b (Z:E-1b = 25:1).
Scheme 4. Preparation of 2-Diazo-N,N-dimethyl-3-(triisopropylsiloxy)pent-3-enamide, 1b (Z:E-1b = 25:1).
Molecules 26 03520 sch004
Scheme 5. Preparation of N,N,3-Trimethyl-2-(triisopropylsiloxy)cycloprop-1-ene-1-carboxamide (5).
Scheme 5. Preparation of N,N,3-Trimethyl-2-(triisopropylsiloxy)cycloprop-1-ene-1-carboxamide (5).
Molecules 26 03520 sch005
Scheme 6. Preparation of 2-Diazo-N,N-dimethyl-3-oxopentanamide (8).
Scheme 6. Preparation of 2-Diazo-N,N-dimethyl-3-oxopentanamide (8).
Molecules 26 03520 sch006
Table 1. Optimization for Catalytic Asymmetric [3 + 1]-Cycloaddition Reaction of 1a with 2a/2b a.
Table 1. Optimization for Catalytic Asymmetric [3 + 1]-Cycloaddition Reaction of 1a with 2a/2b a.
Entry aCatalystLigandYlidet/hT/°C Yield [%] bee [%] c
1CuOTf·Tol1/2L12a18 rt580
2CuOTf·Tol1/2L52b24 rt7464
3CuOTf·Tol1/2L92b16 rt7132
4CuOTf·Tol1/2L102b16 rt7645
5CuOTf·Tol1/2L122b16 rt9038
6CuOTf·Tol1/2L132b16 rt7844
7CuOTf·Tol1/2L142b16 rt5434
8CuOTf·Tol1/2L142b24 0 6038
9CuOTf·Tol1/2L162b24 rt8058
10CuOTf·Tol1/2L172b16 rt7960
11CuOTf·Tol1/2L172b24 0 8264
12 dCuOTf·Tol1/2L172b24 −207468
13CuBF4(CH3CN)4L172b16 rt7959
14CuBF4(CH3CN)4L172b160 7565
15 dCuBF4(CH3CN)4L172b24 −20 8267
a Unless otherwise noted, the reactions were performed as follows: a solution of CuOTf·Tol1/2 (0.01 mmol, 5 mol%), and ligand (0.012 mmol, 6 mol%) in dry DCM (1.0 mL) under N2 was stirred at rt for 1 h, after which sulfur ylide 2a or 2b (0.20 mmol) in dry DCM (0.5 mL) and 1a (0.24 mmol) in dry DCM (0.5 mL) were added at the specified temperature. The reaction solution was stirred at the same temperature for the indicated time. b Isolated yield. c Enantiomeric excess was determined by HPLC analysis on a Chiralpak OD-H column. Negative values specify the opposite enantiomer. d Reactions at −20 °C were performed in a freezer.
Table 2. Ligands screening for Catalytic Asymmetric [3 + 1]-Cycloaddition Reaction of donor acceptor cyclopropene 5 with 2b a.
Table 2. Ligands screening for Catalytic Asymmetric [3 + 1]-Cycloaddition Reaction of donor acceptor cyclopropene 5 with 2b a.
Entry aLigandSolventT/°Ct/hdr (Z:E) bYield (ee) of Z-3b cYield (ee) of E-3b dYield (4) e
1L1DCMrt38(2:1)32% (−12%)12% (65%)47%
2L4DCMrt24(2.5:1)50% (0%)18% (0%)4%
3L5DCMrt24(8:1)28% (−69%)3% (62%)59%
4L11DCMrt24(5:1)40% (62%)8% (56%)44%
5L12DCMrt24(5:1)61% (48%)12% (10%)16%
6L14DCMrt24(12:1)67% (71%)5.5% (16%)8%
7 fL14DCM−2048(24:1)73% (79%)3% (32%)2%
8L16DCMrt38(10:1)57% (59%)6% (NA)22%
9L17DCMrt24(18:1)24% (63%)2% (NA)51%
a Unless otherwise noted, reactions were performed as follows: a solution of CuOTf·Tol1/2 (0.01 mmol, 5 mol%), and ligand L (0.012 mmol, 6 mol%) in dry DCM (1.0 mL) under N2 was stirred at rt for 1 h, after which sulfur ylide 2b (0.20 mmol) in dry DCM (0.5 mL) was added. Then cyclopropene 5 (0.24 mmol) in dry DCM (0.5 mL) was added dropwise at the specific temperature, and the reaction solution was stirred at the same temperature for the indicated time. b dr calculated from the reaction mixture after completion of the reaction. c Isolated yield. d Yield of the E diastereomer was calculated from the 1H NMR analysis of the reaction mixture. e Enantiomeric excess was determined by HPLC analysis on a Chiralpak OD-H column. f Reaction at −20 °C was performed in a freezer.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Joyasawal, S.; Ma, D.; Doyle, M.P. Challenges in the Highly Selective [3 + 1]-Cycloaddition of an Enoldiazoacetamide to Form a Donor–Acceptor Cis-Cyclobutenecarboxamide. Molecules 2021, 26, 3520. https://doi.org/10.3390/molecules26123520

AMA Style

Joyasawal S, Ma D, Doyle MP. Challenges in the Highly Selective [3 + 1]-Cycloaddition of an Enoldiazoacetamide to Form a Donor–Acceptor Cis-Cyclobutenecarboxamide. Molecules. 2021; 26(12):3520. https://doi.org/10.3390/molecules26123520

Chicago/Turabian Style

Joyasawal, Sipak, Donghui Ma, and Michael P. Doyle. 2021. "Challenges in the Highly Selective [3 + 1]-Cycloaddition of an Enoldiazoacetamide to Form a Donor–Acceptor Cis-Cyclobutenecarboxamide" Molecules 26, no. 12: 3520. https://doi.org/10.3390/molecules26123520

Article Metrics

Back to TopTop